Clean both vial tops with alcohol swabs before starting
This is always a clinical decision, but some patterns have emerged in the way providers describe their prescribing preferences: Tirzepatide tends to be preferred for patients seeking maximum weight loss, patients with type 2 diabetes (where the dual mechanism helps glycemic control), and patients who have not responded adequately to semaglutide
BN inhibited meal intake at higher doses for more than 4 hours, leading to weight loss in ob/ob mice after about two weeks of treatment
Though the full comparison, retatrutide vs tirzepatide, isn't finalized, the early indicators suggest that retatrutide could be a more effective option
Serious side effects of weight loss peptides Serious side effects may also occur with GLP-1 medications, though they are rare and may include: Allergic reactions Inflammation of the pancreas (pancreatitis) Gallbladder problems Kidney problems Low blood sugar ( hypoglycemia ) in people with type 2 diabetes (especially when also using other medications that can lower blood sugar) Worsening of diabetic retinopathy (a condition that can cause blood vessel damage in the retina)in people with type 2 diabetes, particularly in those with pre-existing diabetic retinopathy Gastroparesis (severe slowing of stomach emptying) or, even more rarely, bowel obstruction GLP-1 medications contain a black box warning about the potential increased risk for certain thyroid tumors